Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 


Transform Your Metabolic Research

  • Adiponectin
  • Adiponectin Receptor Activation
  • Induction & Analysis of Adipogenesis

Tools for Advancing your Metabolic Research

Metabolism refers to a set of chemical reactions which are responsible for transforming carbohydrates, lipids and proteins into energy. These biochemical processes are essential for maintaining homeostasis. Metabolic research focuses on better understanding basic biological mechanisms that regulate metabolism and how they are dysregulated in disorders such as obesity, diabetes, cardiovascular disease, and cancer. A common root cause in these medical conditions is an energy imbalance; better understanding of this disparity will help determine therapeutic strategies. Even though metabolism involves sequences of complex biochemical reactions, Enzo Life Sciences provides simple and novel solutions to advance your metabolic research.


Discover, Analyse & Quantify Metabolic Biomarkers


Adiponectin is a protein hormone primarily produced by adipocytes which circulates at high levels (5-30 mg/L) in the blood. Adiponectin modulates a number of metabolic processes and is known to contribute to metabolic pathologies including diabetes, atherosclerosis, and obesity. It has been shown to increase insulin sensitivity and decrease plasma glucose by increasing tissue fat oxidation.


Modulation of Glucose & Lipid Metabolism

Recombinant Human Adiponectin

HMW Adiponectin Delivering Superior In Vitro Activity

Quantify Adiponectin

Adiponectin (human), ELISA Kit

A Rapid, High-sensitivity ELISA Kit for Quantification of Human Adiponectin

Adiponectin Receptor Activation


A Novel Small Molecule Adiponectin Mimetic

Proinsulin and Insulin Secretion

Insulin ELISA kit

Highly sensitive Insulin ELISA kit enabling detection of insulin in serum, plasma, tissue culture media in just 3 hours.

Proinsulin ELISA kit

Ultra-sensitive Proinsulin ELISA kit enabling detection of proinsulin in human serum and plasma samples in just 3 hours.

Leptin Sensitivity

Leptin (mouse), (recombinant)

[pTyr705]STAT3 monoclonal antibody (9E12)

c-Fos polyclonal antibody

Diabetes / Obesity Modulators

PPAR Agonists

PPAR Antagonist


Antidiabetic Agents

Modulators of Browning

Irisin (human), (recombinant) (active)

PPAR Ligands


Adrenergic Agonists

Induction & Analysis of Adipogenesis

Adipogenesis Assay Kit

Convenient Method For the Enhanced Induction and Detection of Adipogenesis

Adipogenesis Dye Allows for Visual Confirmation of Adipocyte Differentiation

3T3-L1 cells were treated with and without induction media. After 10 days, cells were stained with Adipogenesis Dye and imaged at 40x magnification.


Obesity is associated with a low-grade inflammation of white adipose tissue (WAT) resulting from chronic activation of the innate immune system. Downstream, this can lead to insulin resistance, impaired glucose tolerance and even diabetes. Understanding the mechanisms leading to disease will help in developing new approaches to its treatment and prevention.


GLP and Exendin

GLP (glucagon-like peptide) functions in the regulation of blood glucose through insulin, and plays a role in obesity and diabetes. GLP-1 is an important gastrointestinal peptide hormone or incretin, which is released when we eat, produced by tissue specific post-translational processing from a glucagon precursor, and inactivated by dipeptidylpeptidase DPP-4 enzymes. Exendin-4 is a 39 amino-acid peptide found in venom from the Gila monster. It is a member of the glucagon-secretin family of peptide hormones and neuropeptides. As an agonist of the GLP-1 receptor, Exendin-4 is a potent stimulator of insulin secretion and has a much longer half life than GLP-1 (~2 minutes) making it a suitable drug candidate for the treatment of obesity and type-2 diabetes.

  • AMP’D® GLP-1 ELISA Kit
  • GLP Antibodies
  • Exendin Antibodies
  • GLP Proteins
  • Exendin-4 Protein

Lipocalin-2, Neutrophil Gelatinase-associated Lipocalin (NGAL)

NGAL (also known as Lipocalin-2 or Neutrophil Gelatinase-associated Lipocalin) is a small, ~25kDa secreted protein expressed in epithelial tissues and released into both urine and blood upon kidney tubular damage. The protein is protease resistant and over-expressed during inflammation, infection and certain cancers. During acute renal failure (ARF) caused by either ischemia or nephrotoxicity, NGAL is secreted in high levels into blood and urine within 2 hours or less of injury to the kidney. NGAL is also released at the time of acute kidney injury (AKI) unlike serum creatinine, another kidney diagnostic biomarker which may not be seen until 72 hours after injury when up to 50% of renal function may have been lost.

  • NGAL Antibodies
  • NGAL Proteins


Adipose tissue contains differentiated cells called adipocytes that are specialized in storing fat. In addition to their function in controlling energy homeostasis, adipocytes release endocrine and paracrine signaling molecules called adipokines that are important in many physiological and metabolic processes. Some adipokines such as adiponectin, omentin, Nampt (Visfatin/PBEF), resistin or RBP4 are involved in insulin signaling. Others regulate food intake and lipid metabolism (e.g. leptin, chemerin).

Sphingolipid Metabolism

Sphingolipids are a versatile class of membrane lipid. Sphingolipid metabolites, such as ceramide, sphingosine, and sphingosine-1-phospate are lipid signaling molecules which are involved in diverse cellular processes. Sphingosine can be phosphorylated in vivo via two kinases, sphingosine kinase type 1 and sphingosine kinase type 2, leading to the formation of sphingosine-1-phosphate (S1P). Sphingosine-1-phosphate is a potent signaling lipid involved in numerous biological functions including, cellular proliferation, survival, migration, invasion, differentiation, architecture, immune cell trafficking, angiogenesis and vascular integrity.


Detect Metabolic Analytes Accurately & Efficiently

Dysregulation in metabolic pathways results in some of the most devastating global healthcare challenges we face today such as obesity, diabetes, cardiovascular disease and cancer. Metabolic biomarkers play an important role in both diagnosis and prognosis.


Simplify Your Research With ELISA Kits

Built upon our diverse scientific expertise and technology platforms, Enzo solutions enable you to advance your metabolic research with more than 250 ELISA kits for accurate detection of your specific analyte.


Quantify difficult-to-detect analytes

Reliable detection of analytes that are present at low concentrations is a critical need for early diagnosis and treatment of various diseases. Enzo Life Sciences has developed a highly sensitive ELISA Amplification System to be used with your most difficult-to-detect markers.

  • Increase sensitivity up to 50-fold over traditional ELISA
  • Minimal additional time needed to complete amplification step
  • Flexible format for use with any immunometric, sandwich ELISAs where greater sensitivity is desired
  • Convenient one or five 96-well plate sizes for high throughput analysis
  • Easy-to-use, simple procedure with nominal ELISA protocol modification

ELISAs based on Amp’d™ Technology


Sensitive and rapid AMP'D® GLP-1 ELISA kit enabling the ability to use less sample to detect levels of human Glucagon-like peptide 1 (7-36) amide, a potent promoter of insulin secretion and therapeutic for type 2 diabetes.

  • Ultra-sensitive measurement of GLP-1, detecting as little as 5.5 pg/ml
  • Negligible reactivity from similar GLP-1 forms
  • High throughput format with results in 3 hours for up to 40 samples in duplicate
  • Fully quantitative results that surpass semi-quantitative Western blot analysis


Related Literature and Documents

Featured TechNotes

Insulin Signaling
2021 August 13 | Tags: Drug Discovery, Metabolism, Infographic

Cinnamon Triggers Weight Loss
2017 December 19 | Tags: Metabolism, In The News

A Wind of Change with Wnt
2014 July 11 | Tags: Metabolism

Season your life!
2014 June 27 | Tags: Metabolism

Latest Literature

Transform Your Metabolic Research

Recommend this page